Medical history has recently been made in a New York City hospital. This month, 21-year-old Sebastien Beauzile became the ...
Scientists from Johns Hopkins Medicine and eight other institutions in the United States, Africa and Europe say they have ...
Sebastien Beauzile, 21, is the first New Yorker to have received the breakthrough Lyfgenia treatment, according to the New ...
Amblest Kanu, a graduate of Medical Laboratory Science, Faculty of Clinical Sciences, Lead City University, Oyo State, tells AYOOLA OLASUPO about some of the challenges he faced as a sickle cell ...
A New Jersey Assembly bill that would add sickle cell anemia to the list of qualifying medical marijuana conditions has ...
Sebastien Beauzile’s recently announced cure from sickle cell disease brings hope to thousands of mostly Black Americans who ...
because in areas where malaria is common, there is a fitness benefit in carrying only a single sickle-cell gene (sickle cell trait). Those with only one of the two alleles of the sickle-cell ...
Sickle cell disease is a genetic blood disorder characterised ... which can be beneficial in individuals with SCD-related anemia. However, excessive iron absorption from vitamin C supplementation ...
It is well-established that patients with sickle cell disease (SCD) are at substantial risk of neurological ... hypercoagulability, thrombosis, hemolytic anemia, and hypoxia, as well as the ...
People with sickle cell disease are immunocompromised, which means they have an increased risk of infection. For this reason, immunizations are an important part of complete sickle cell care. This ...
Next review: More evidence on exagamglogene autotemcel is being collected. After this, NICE will decide whether to recommend it for use in the NHS and update the guidance. It will be available with ...